Abstract:Increased stemness is causally linked to the development of chemoresistance in cancers. B-cell receptor-associated protein 31 (BAP31) has been identified to play an oncogenic role in many types of cancer. However, the role of BAP31 in 5-fluorouracil (5-FU) chemosensitivity and stemness of colorectal cancer (CRC) is still unknown. The aim of this study was to investigate the biological function and molecular mechanism of BAP31 in regulating 5-FU chemosensitivity and stemness. The correlation between BAP31 expression and 5-FU chemosensitivity was examined using 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide and colony formation assays. Cancer stemness was analyzed using tumor sphere formation and Western blot assays. Western blot and immunofluorescence analyses of the knockdown cell lines were performed to explore the possible mechanisms. Finally, we investigated the function of BAP31 by constructing xenograft nude mouse models in vivo. In this study, we demonstrated that BAP31 was increased in CRC cells, and knockdown of BAP31 reduced the half maximal inhibitory concentration (IC50) of 5-FU, while this effect was reversed by overexpression of BAP31. In addition, knockdown of BAP31 substantially reduced the stemness of CRC cells in vitro. Consistently, knockdown of BAP31 significantly suppressed the tumorigenicity and stemness of CRC in vivo. The functional study further suggested that knockdown of BAP31 downregulated galectin-3 to inhibit the accumulation of β-catenin, which in turn repressed the transcription of downstream target genes (c-MYC, SOX2) of the Wnt/β-catenin signaling pathway. Knockdown of BAP31 reduced stemness by inhibiting the Wnt/β-catenin signaling pathway to increase 5-FU chemosensitivity. Importantly, intrabodies against BAP31 suppressed tumor growth and enhanced the antitumor effects of 5-FU in vivo. Therefore, using intrabodies against BAP31 may be a strategy for improving the antitumor effect of 5-FU in CRC.

Knockdown of BAP31 Overcomes Hepatocellular Carcinoma Doxorubicin Resistance through Downregulation of Survivin

Chemoresistance is Associated with Overexpression of HAX-1, Inhibition of Which Resensitizes Drug-Resistant Breast Cancer Cells to Chemotherapy.

B-Cell Receptor-Associated Protein 31 Promotes Metastasis Via AKT/β-Catenin/Snail Pathway in Hepatocellular Carcinoma

Apatinib-induced NF-κB Inactivation Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin.

Knockdown of BAP31 Downregulates Galectin-3 to Inhibit the Wnt/β-Catenin Signaling Pathway to Modulate 5-FU Chemosensitivity and Cancer Stemness in Colorectal Cancer

Overexpression of Yes-associated Protein Confers Doxorubicin Resistance in Hepatocellullar Carcinoma.

BAP31 Promotes Tumor Cell Proliferation by Stabilizing SERPINE2 in Hepatocellular Carcinoma

Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part Through the Inhibition of the Phosphatidylinositol 3-Kinase/akt Pathway

Overexpression of Bax Induces Apoptosis and Enhances Drug Sensitivity of Hepatocellular Cancer-9204 Cells.

BAP31 Regulates Wnt Signaling to Modulate Cell Migration in Lung Cancer

BAP18 Acting As a Novel Peroxisome Proliferator-Activated Receptor Α Co-Regulator Contributes to Hepatocellular Carcinoma Progression.

BAP31 promotes breast cancer progression by interaction with SERCA2

Inhibition of BAP31 Expression Inhibits Cervical Cancer Progression by Suppressing Metastasis and Inducing Intrinsic and Extrinsic Apoptosis

Knockdown Of Heme Oxygenase-1 Promotes Apoptosis And Autophagy And Enhances The Cytotoxicity Of Doxorubicin In Breast Cancer Cells

Crizotinib and Doxorubicin Cooperatively Reduces Drug Resistance by Mitigating MDR1 to Increase Hepatocellular Carcinoma Cells Death

Deubiquitinase Inhibitor B-Ap15 Activates Endoplasmic Reticulum (ER) Stress and Inhibits Wnt/Notch1 Signaling Pathway Leading to the Reduction of Cell Survival in Hepatocellular Carcinoma Cells

Down-regulation of UBC9 Increases the Sensitivity of Hepatocellular Carcinoma to Doxorubicin.

Effects of the Proapoptotic Regulator Bcl-2/Adenovirus Eib 19-Kda-interacting Protein 3 on the Chemosensitivity of Human Colon Cancer Cell Lines

Smac Mimetic SM-164 Potentiates APO2L/TRAIL- and Doxorubicin-Mediated Anticancer Activity in Human Hepatocellular Carcinoma Cells.

Apatinib (YN968D1) Enhances the Efficacy of Conventional Chemotherapeutical Drugs in Side Population Cells and ABCB1-overexpressing Leukemia Cells

BAP1 suppresses lung cancer progression and is inhibited by miR-31.